Congenital human immunodeficiency virus
MONDO:0022839Also known as: congenital HIV, neonatal HIV, neonatal human immunodeficiency virus
10 clinical trials for this condition and its sub-types, 5 tagged with Congenital human immunodeficiency virus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Supercharged donor cells take on viruses after transplant
Disease control Recruiting nowThis study tests whether specially grown donor immune cells (viral-specific T-cells) can safely treat viral infections that often occur after a stem cell transplant. These infections can be serious and sometimes don't respond to standard antiviral drugs. The approach aims to boos…
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can donor cells stop viruses after transplant?
Disease control Recruiting nowThis study tests whether giving patients donor-derived immune cells (VSTs) on a regular schedule can prevent dangerous viral infections after a stem cell transplant. 180 participants will be randomly assigned to receive VSTs either on a fixed schedule or only when a virus is dete…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can peer mentors help stop HIV transmission from mother to child?
Disease control Recruiting nowThis study tests an enhanced Mentor Mother strategy, where trained peer counselors provide tailored support to pregnant and postpartum women living with HIV. The goal is to see if this approach can be successfully implemented and improve health outcomes, such as keeping mothers i…
Sponsor: Indiana University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Texting for health: could a simple WhatsApp nudge boost HIV protection?
Prevention Recruiting nowThis study is testing whether weekly WhatsApp messages can help sexual and gender minorities in Brazil stay on track with HIV prevention (PrEP) and treatment (ART). Participants will be randomly assigned to receive either the messages or no messages for six months. The study will…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC